Alternatives to BenchSci

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI-powered insights platform for life sciences and biotech workflows.

Generative AI platform empowering life science domain experts to accelerate research and reduce errors.

Biopanel extracts every biomarker from your lab report PDFs and tracks their trends over time. Coming soon — watch the demo.

Biotech diligence research workbench

Kezako is a French startup developing an AI-powered platform for scientific research and discovery.

AI-powered predictive analytics for clinical trials and drug discovery.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

AI-powered platform accelerating biological research and drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Personalized computational drug screening for rare diseases using patient genetics and automation.

Global marketplace connecting researchers with human biospecimens for life science research.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Life science company pioneering drug discovery with AI and advanced technologies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Cellbox Labs develops and manufactures portable CO2 incubators for the safe and stable transport of living cells and biological materials.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

A global oncology company developing and commercializing innovative cancer treatments.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

A peptide synthesis company focused on quality, speed, and affordability for researchers.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.